All of the information I have read about Professor Grube indicates to me that the man is a Legend in the field of TAVR, so to have him talking about the DurAVR at these prestigious conferences is great news indeed.
It's been discussed here before although as a quick reminder to investors new to this forum, CoreValve, was bought my Medtronic for $700 million US + add ons, speculated to be just over $1 Billion US (or $1.5 Billion Aus) in 2009.
This purchase has always provided a foundation on which I base future MINIMUM takeover amounts of the DurAVR keeping a couple of very important things in mind. 1) Our TAVR device wipes the floor with the CoreValve device and 2) the TAVR market is so much bigger than anyone knew or expected it to grow into in 2009.
Two compelling reasons why any purchase of the DurAVR should be many multiples higher than the CoreValve purchase price.
AVR Price at posting:
$22.37 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)